Company: SCYX
Filing Date: 2025-03-12
Form Type: 10-K
Source: 0000950170-25-038044
Chunk: 179

Company: SCYNEXIS INC
Filing Date: 2025-03-12
Form: 10-K
Item: Item 1B
Chunk 179
---
S BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints David Angulo, M.D. and Scott Sukenick, as his or her true and lawful attorney-in-fact and agent, with full power of substitution for him or her, and in his or her name in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent, full power and authority to do and perform each and every act and thing requisite and necessary to be done therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, and any of them or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof. 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.  

    Signature
     
    Title
     
    Date

    /s/ David Angulo, M.D.
     
    Chief Executive Officer
     
    March 11, 2025

    David Angulo, M.D.
     
    (Principal Executive Officer)

    /s/ Ivor Macleod
     
    Chief Financial Officer
     
    March 11, 2025

    Ivor Macleod
     
    (Principal Financial and Accounting Officer)

    /s/ Guy Macdonald
     
    Director
     
    March 11, 2025

    Guy Macdonald

    /s/ David Hastings
     
    Director
     
    March 11, 2025

    David Hastings

    /s/ Steven C. Gilman, Ph.D.
     
    Director
     
    March 11, 2025

    Steven C. Gilman, Ph.D.

    /s/ Ann F. Hanham, Ph.D.
     
    Director
     
    March 11, 2025

    Ann F. Hanham, Ph.D.

    /s/ Armando Anido
     
    Director
     
    March 11, 2025